53

Vivanza Biosciences LtdBOM 530057 Stock Report

Last reporting period 31 Mar, 2024

Updated 19 Sep, 2024

Last price

Market cap $B

0.002

Micro

Exchange

XBOM - Bombay Stock Exchange

530057.BO Stock Analysis

53

Avoid

Based on Eyestock quantitative analysis, 530057.BO`s fundamental data and valuation indicate an investment grade of Avoid at the current time.

Rating

To assess the quality of a company's business, we have collected all financial data from the statements and presented them in the form of a single number - the company's rating. Rating value of 100 is the threshold for determining a viable investment.

37/100

Low score

Upside

To determine whether the current price is a reasonable to buy a stock, we compare it to our estimate of fair value. The more undervalued a stock is, the higher the upside.

237.5 %

Greatly undervalued

Market cap $B

0.002

Dividend yield

Shares outstanding

40 B

Vivanza Biosciences Ltd. engages in the manufacture and trade of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm offers pharmaceutical products and pharma products. The firm is focused on commercializing generic pharmaceuticals, offering patients accessible medicines. The firm operates in only one that is trading of pharmaceutical product. Its products include gloves and surgical. Gloves products include latex examination gloves powdered, latex surgical powdered, latex free examination gloves-vinyl, latex free examination gloves-nitrile and Latex examination gloves-powdered. The Company’s products catalogues include Injectable Products, Vivanza Gloves and Therapeutic Index Injection. The firm offers gloves and surgical products to the industries include chemical, energy, industry, manufacturing and materials.

View Section: Eyestock Rating